Two weeks after the European Medicines Agency first assured EU member states it had found no link between the Oxford/AstraZeneca vaccine and earlier reports of rare blood clots, a growing number of countries have announced new restrictions on the use of the jab.
兩周前，歐洲藥品管理局(European Medicines Agency)首次向歐盟成員國保證，它沒有發現牛津/阿斯利康(Oxford/AstraZeneca)疫苗與早些時候報告的罕見血栓病例存在聯系，而現在已有越來越多的國家宣布限制接種該疫苗。
您已閱讀4%（386字），剩余96%（9573字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。